Skip to main content
. 2017 Sep 19;2017:4078346. doi: 10.1155/2017/4078346

Table 2.

ncRNAs causing cardiovascular diseases.

ncRNA Disease condition Effect Description
miRNAs

miR-378
miR-122
miR-29
miR-26
Cardiac fibrosis Negative, prognostic/diagnostic Abnormal expression could induce cardiac fibrosis targeting TFG-β including miRNA [15]

miR-126
miR-17-92 cluster
Endothelial dysfunction and inflammation Negative, prognostic Negative regulation of angiogenesis in epithelial cells [9]

miR-221
miR-222
miR-155
Initial stages of atherosclerosis Positive, therapeutic Inflammatory response of endothelial cells and showing antiangiogenic effects [9, 22]

miR-143
miR-145
Injured or atherosclerosis Negative, prognostic Regulation of phenotype of VSMCs in response to injury [9]

miR-21
miR-146a
Vascular injury Positive, therapeutic Phenotypic modulation of VSMCs [9]

miR-208a Acute Myocardial Infarction (AMI) Negative, prognostic/diagnostic Causes hypertrophic cardiac growth and fibrosis [13]

miR-23a Pathological hypertrophy Negative, prognostic/therapeutic Upregulated as a result of hypertrophic stimuli in cardiomyocytes, downregulation can be done by ASO [13]

miR-29
miR-24
miR-320
Fibrosis and scar formation Negative, prognostic Expression levels drop after a myocardial infarction [13]

miR-19
miR-21
miR-146
miR-155
miR-133
Acute Coronary Syndrome (ACS) and coronary artery disease (CAD) Negative, prognostic/diagnostic Microparticles from plasma shows elevated amounts in ACS patients when compared to CAD patients [10, 23]

miR-1
miR-133
miR-208a
 Arrhythmias Diagnostic The presence of these miRNAs can be used as diagnostic features for arrhythmia, fibrosis, and metabolic disorders [24]
miR-21
miR-29
Fibrosis Diagnostic
miR-33 Metabolic disorders Diagnostic

circRNAs

Heart Related Circular RNA (HRCR) Cardiac hypertrophy and heart failure Positive, prognostic/therapeutic Protects the heart from pathological conditions caused by miR-223 by acting as its miRNA sponge resulting in increased amounts of ARC expressions. HRCR is therefore a target for drug development [15]

Cdr1as Myocardial infarction injuries Negative, prognostic miR-7 sponge, the target genes of miR-7 are SP1 and PARP (poly-ADP-ribose polymerase) and they cause cell apoptosis; therefore the reduction in miR-7 increases the cell apoptosis causing SP1 and PARP [15]

Circ-Foxo3 Cardiac senescence Negative, diagnostic Highly expressed in patients and causes cells to be held up at G1 phase unable to transit to S phase. Represses cell cycle progression and proliferation [15].

Circular Antisense non coding RNA in INK4 locus (cANRIL) Atherosclerosis risk Negative, diagnostic Regulate atherosclerosis [15]